Senior insider sale
Senior Vice President at APELLIS PHARMACEUTICALS, INC. — senior position signals high conviction
$147.4K
6.85K shares
What this filing means
DELONG MARK JEFFREY plans to sell 6.85K shares of APELLIS PHARMACEUTICALS, INC. valued at approximately $147.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2026ACC: 0001959173-26-000886
Officer· Senior Vice President
Since Mar 2021
6.85K
Shares to sell
$147.4K
Approx. market value
368.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/10/2026
368.00Total acquired368.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2026 | Restricted Stock Vesting Compensation | 368.00 | — |
| Total | 368.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
3.37K
Market value
$73.4K
1/22/2026
—Completed
Units to sell
1.33K
Market value
$26.4K
1/20/2026
—Completed
Units to sell
1.78K
Market value
$39.5K
1/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
368.00
Market value
$8.2K
2/11/2026
Total
Units
6.85K
Value
$147.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/22/2026 | 3.37K | $73.4K | — | Completed |
1/20/2026 | 1.33K | $26.4K | — | Completed |
1/13/2026 | 1.78K | $39.5K | — | Completed |
| Planned — Approximate Date | ||||
2/11/2026 | 368.00 | $8.2K | NASDAQ | Planned |
| Total | 6.85K | $147.4K | ||